InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52
United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Sanjiv Patel
7 Oct 2026
President and CEO
Sold on a plan
48,199
$18.10
$872.40K
Thomas Catinazzo
6 Oct 2026
Chief Financial Officer
Sold on a plan
206
$19.26
$3.97K
Thomas Catinazzo
6 Oct 2026
Chief Financial Officer
Sold on a plan
17,511
$18.58
$325.35K
Sanjiv Patel
8 Sep 2026
President and CEO
Sold on a plan
48,199
$18.94
$912.89K
Thomas Catinazzo
8 Sep 2026
Chief Financial Officer
Sold on a plan
17,717
$18.94
$335.56K
Donald A Bergstrom
8 Sep 2026
President, R&D
Sold on a plan
8,530
$18.97
$161.81K
Peter Rahmer
26 Aug 2026
See remarks
Sold on a plan
4,508
$20.03
$90.30K
Sanjiv Patel
17 Aug 2026
President and CEO
Sold on a plan
48,199
$20.33
$979.89K
Thomas Catinazzo
14 Aug 2026
Chief Financial Officer
Sold on a plan
17,717
$19.74
$349.73K
Sanjiv Patel
7 Jul 2026
President and CEO
Sold on a plan
48,199
$19.58
$943.74K
Thomas Catinazzo
6 Jul 2026
Chief Financial Officer
Sold on a plan
17,717
$18.69
$331.13K
Donald A Bergstrom
6 Jul 2026
President, R&D
Sold on a plan
8,660
$18.71
$162.03K
Peter Rahmer
30 Jun 2026
See remarks
Sold on a plan
50,000
$19.09
$954.50K
Thomas Catinazzo
14 May 2026
Chief Financial Officer
Sold on a plan
17,717
$12.86
$227.84K
Thomas Catinazzo
7 Apr 2026
Chief Financial Officer
Sold on a plan
17,717
$13.01
$230.50K
Thomas Catinazzo
9 Mar 2026
Chief Financial Officer
Sold on a plan
17,717
$10.06
$178.23K
Show all 39 transactions →

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 6
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 272,802
History held since 20 Jul 2020